CM Life Sciences III Shares & Warrants May be Traded Separately

Casdin Capital

CM Life Sciences III said its shares of Class A common stock and redeemable warrants may be traded separately starting May 28.

Shares and warrants that are separated will trade on the Nasdaq under CMLT and CMLTW, respectively. Units not separated will continue to trade on Nasdaq under the symbol CMLTU.

CM Life Sciences III raised $552 million in an IPO last month. This is the latest SPAC launched by CEO Eli Casdin, founder of Casdin Capital, an investment firm focused on the life sciences and healthcare industry. Read more.

Total
0
Shares
Related Posts
B. Riley
Read More

B. Riley Principal 250 Prices $150M IPO

The SPAC said it intends "to focus on businesses that have a history of, or potential for, strong cash flow generation and growing revenue streams, and would benefit from access to public markets and the operational and strategic expertise of its management team and board of directors."